All Madopar® preparations re-classified as special containers
Following representations from PSNC and Roche Products Ltd, the Department of Health of Social Care (DHSC) has re-determined that all six Madopar® (Co-beneldopa) preparations meet the special container criteria as outlined in Part II Clause 10 of the Drug Tariff. The NHS dictionary of medicines and devices (dm+d) has now been updated with special container
Read more